NAB-paclitaxel and breast cancer: The Lancet Oncology: February 8, 2016

The Lancet Oncology in conversation with - A podcast by The Lancet Group

Categories:

Education

Sibylle Loibl discusses the findings and clinical implications of the GeparSepto trial. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv